Biotechnology in the United Kingdom

Biotechnology in the United Kingdom


  • Products Id :- OHMF4551
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotechnology in the United Kingdom

Summary

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the United Kingdom biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The UK biotechnology industry had total revenues of USD 9.3bn in 2017, representing a compound annual growth rate (CAGR) of 5.9% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 6.1bn, equivalent to 66% of the industry's overall value.

- The UK's industry is mainly driven by biotechnology related to healthcare, segments that are boosted by the talented pool of scientists in the country.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts

Reasons to buy

- What was the size of the United Kingdom biotechnology market by value in 2017?

- What will be the size of the United Kingdom biotechnology market in 2022?

- What factors are affecting the strength of competition in the United Kingdom biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the United Kingdom's biotechnology market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

AstraZeneca PLC 20

GE Healthcare 23

Novartis AG 24

Sanofi SA 28

Macroeconomic Indicators 31

Country data 31

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35

List of Figures

Figure 1: United Kingdom biotechnology industry value: USD billion, 2013-17

Figure 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2017

Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: United Kingdom biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2017

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities

List of Tables

Table 1: United Kingdom biotechnology industry value: USD billion, 2013-17

Table 2: United Kingdom biotechnology industry category segmentation: USD billion, 2017

Table 3: United Kingdom biotechnology industry geography segmentation: USD billion, 2017

Table 4: United Kingdom biotechnology industry value forecast: USD billion, 2017-22

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials (USD )

Table 7: AstraZeneca PLC: key financial ratios

Table 8: GE Healthcare: key facts

Table 9: Novartis AG: key facts

Table 10: Novartis AG: key financials (USD )

Table 11: Novartis AG: key financial ratios

Table 12: Sanofi SA: key facts

Table 13: Sanofi SA: key financials (USD )

Table 14: Sanofi SA: key financials (EUR)

Table 15: Sanofi SA: key financial ratios

Table 16: United Kingdom size of population (million), 2013-17

Table 17: United Kingdom gdp (constant 2005 prices, USD billion), 2013-17

Table 18: United Kingdom gdp (current prices, USD billion), 2013-17

Table 19: United Kingdom inflation, 2013-17

Table 20: United Kingdom consumer price index (absolute), 2013-17

Table 21: United Kingdom exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24500
Site License
USD 700 INR 49000
Corporate User License
USD 1050 INR 73500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com